Csiha, S.; Hernyák, M.; Molnár, Á.; Lőrincz, H.; Katkó, M.; Paragh, G.; Bodor, M.; Harangi, M.; Sztanek, F.; Berta, E.
Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy. Biomedicines 2025, 13, 438.
https://doi.org/10.3390/biomedicines13020438
AMA Style
Csiha S, Hernyák M, Molnár Á, Lőrincz H, Katkó M, Paragh G, Bodor M, Harangi M, Sztanek F, Berta E.
Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy. Biomedicines. 2025; 13(2):438.
https://doi.org/10.3390/biomedicines13020438
Chicago/Turabian Style
Csiha, Sára, Marcell Hernyák, Ágnes Molnár, Hajnalka Lőrincz, Mónika Katkó, György Paragh, Miklós Bodor, Mariann Harangi, Ferenc Sztanek, and Eszter Berta.
2025. "Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy" Biomedicines 13, no. 2: 438.
https://doi.org/10.3390/biomedicines13020438
APA Style
Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., & Berta, E.
(2025). Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy. Biomedicines, 13(2), 438.
https://doi.org/10.3390/biomedicines13020438
